Ohio State University Comprehensive Cancer Center – Developmental Therapeutics Review – Q4 2010

Date: November 1, 2010
Pages: 40
Price:
US$ 500.00
License [?]:
Publisher: Global Markets Direct
Report type: Company Report
Delivery: E-mail Delivery (PDF)
ID: OFDB3E01371EN
Leaflet:

Download PDF Leaflet

Ohio State University Comprehensive Cancer Center – Developmental Therapeutics Review – Q4 2010
Summary

Global Market Direct’s pharmaceuticals report, “Ohio State University Comprehensive Cancer Center – Developmental Therapeutics Review – Q4 2010” provides data on the institute’s research and development focus. The report includes information on therapeutics under development, complete with latest updates, and features on discontinued projects (if applicable). It also gives a complete picture of the institute’s future therapy areas of focus.

This report is built using data and information sourced from Global Markets Direct’s proprietary databases, primary and secondary research using institute’s website, and featured press releases, both from institute and industry-specific third party sources, put together with in-house analysis, by Global Markets Direct’s team of industry experts.

Scope

- Review of therapeutics under development by Ohio State University Comprehensive Cancer Center.
- Overview of products under development across various therapy areas.
- Coverage of therapeutic molecules in various stages of drug development, including the combination treatment modalities, for the pharmaceutical markets across the globe.
- Product profiles for late stage and clinical stage products of Ohio State University Comprehensive Cancer Center with complete description of the product’s developmental history, mechanism of action, clinical trials, major milestones and others.
- Recent updates of Ohio State University Comprehensive Cancer Center’s therapeutic products in the last quarter.
- Latest news and deals relating to the products.

Reasons to buy

- Identify new drug targets and therapeutic classes in Ohio State University Comprehensive Cancer Center’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying opportunities to fill portfolio gaps.
- Evaluate Ohio State University Comprehensive Cancer Center’s position with total access to a detailed intelligence on its therapeutic products development.
- Assess the growth potential of Ohio State University Comprehensive Cancer Center in its therapy areas of focus.
- Exploit collaboration and partnership opportunities with Ohio State University Comprehensive Cancer Center.
- Avoid Intellectual Property Rights related issues.
- Undertake deals with an understanding of the mergers and partnerships that have shaped the sector.
1 TABLE OF CONTENTS

1.1 List of Tables
1.2 list of Figures

2 INTRODUCTION
3 OHIO STATE UNIVERSITY COMPREHENSIVE CANCER CENTER - RESEARCH AND DEVELOPMENT OVERVIEW

3.1 Key Therapeutic Areas

4 OHIO STATE UNIVERSITY COMPREHENSIVE CANCER CENTER - INVESTIGATIONAL PRODUCTS REVIEW

4.1 Products by Stage of Development
4.2 Products - Monotherapy
4.3 Products - Combination Treatment Modalities

5 OHIO STATE UNIVERSITY COMPREHENSIVE CANCER CENTER - INVESTIGATIONAL PRODUCTS GLANCE

5.1 Ohio State University Comprehensive Cancer Center - Phase III Products
5.2 Ohio State University Comprehensive Cancer Center - Phase II Products
5.3 Ohio State University Comprehensive Cancer Center - Phase I Products
5.4 Ohio State University Comprehensive Cancer Center - Pre-Clinical and Discovery Products

6 OHIO STATE UNIVERSITY COMPREHENSIVE CANCER CENTER - DRUG PROFILES

6.1 Product 1 - Product Profile
  6.1.1 Product Description
  6.1.2 Mechanism of Action
  6.1.3 R&D Progress

7 OHIO STATE UNIVERSITY COMPREHENSIVE CANCER CENTER - INVESTIGATIONAL PRODUCTS ANALYSIS

7.1 Ohio State University Comprehensive Cancer Center Products by Therapeutic Class
7.2 Ohio State University Comprehensive Cancer Center Products by Target
7.3 Ohio State University Comprehensive Cancer Center by Route of Administration
7.4 Ohio State University Comprehensive Cancer Center Products by Molecule Type

8 OHIO STATE UNIVERSITY COMPREHENSIVE CANCER CENTER - RECENT PRODUCT UPDATES
9 OHIO STATE UNIVERSITY COMPREHENSIVE CANCER CENTER - FEATURED NEWS
10 OHIO STATE UNIVERSITY COMPREHENSIVE CANCER CENTER - LOCATIONS
11 APPENDIX

11.1 Global Markets Direct Research Methodology
11.2 Coverage
11.3 Secondary Research
11.4 Primary Research
11.5 Models
11.6 Expert Panels
11.7 Contact Us
11.8 Disclaimer

LIST OF TABLES

Table 1: Ohio State University Comprehensive Cancer Center - Key Therapeutic Areas
Table 2: Ohio State University Comprehensive Cancer Center - Products by Stage of Development,
Table 3: Ohio State University Comprehensive Cancer Center - Monotherapy Products under Investigation,
Table 4: Ohio State University Comprehensive Cancer Center - Combination Treatment Modalities under Investigation,
Table 5: Ohio State University Comprehensive Cancer Center - Phase III Products,
Table 6: Ohio State University Comprehensive Cancer Center - Phase II Products,
Table 7: Ohio State University Comprehensive Cancer Center - Phase I Products,
Table 8: Ohio State University Comprehensive Cancer Center - Pre-Clinical and Discovery Products,
Table 9: Ohio State University Comprehensive Cancer Center - Products By Therapeutic Class
Table 10: Ohio State University Comprehensive Cancer Center - Products By Target
Table 11: Ohio State University Comprehensive Cancer Center - Products By Route of Administration
Table 12: Ohio State University Comprehensive Cancer Center - Products By Molecule Type
Table 13: Ohio State University Comprehensive Cancer Center - Recent Product Updates

LIST OF FIGURES

Figure 1: Ohio State University Comprehensive Cancer Center - Research and Development Overview
Figure 2: Ohio State University Comprehensive Cancer Center - Products by Stage of Development,
Figure 3: Ohio State University Comprehensive Cancer Center - Monotherapy Products,
Figure 4: Ohio State University Comprehensive Cancer Center - Combination Treatment Modalities,
Figure 5: Ohio State University Comprehensive Cancer Center - Products By Therapeutic Class and Stage of Development
Figure 6: Ohio State University Comprehensive Cancer Center - Products By Therapeutic Class
Figure 7: Ohio State University Comprehensive Cancer Center - Products By Target and Stage of Development
Figure 8: Ohio State University Comprehensive Cancer Center - Products By Target
Figure 9: Ohio State University Comprehensive Cancer Center - Products By Route of Administration and Stage of Development
Figure 10: Ohio State University Comprehensive Cancer Center - Products By Route of Administration
Figure 11: Ohio State University Comprehensive Cancer Center - Products By Molecule Type and Stage of Development
Figure 12: Ohio State University Comprehensive Cancer Center - Products By Molecule Type

COMPANIES MENTIONED

Ohio State University Comprehensive Cancer Center

Ask Your Question

Ohio State University Comprehensive Cancer Center – Developmental Therapeutics Review – Q4 2010
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry: